Australia markets closed

Poseida Therapeutics, Inc. (2RZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.5980-0.0480 (-1.81%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
64,703
64,703
130,492
31,238
0
Operating expenses
Research development
156,772
156,772
152,899
136,734
103,520
Selling general and administrative
37,435
37,435
37,539
35,915
23,029
Total operating expenses
194,207
194,207
190,438
172,649
126,549
Operating income or loss
-129,504
-129,504
-59,946
-141,411
-126,549
Interest expense
8,671
8,671
6,370
3,358
3,506
Total other income/expenses net
14,852
14,852
2,858
19,795
280
Income before tax
-123,323
-123,323
-63,458
-124,974
-129,775
Income tax expense
107
107
544
0
0
Income from continuing operations
-123,430
-123,430
-64,002
-124,974
-129,775
Net income
-123,430
-123,430
-64,002
-124,974
-129,775
Net income available to common shareholders
-123,430
-123,430
-64,002
-124,974
-129,775
Basic EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Diluted EPS
-1.54
-1.37
-0.89
-2.01
-3.61
Basic average shares
87,768
90,185
71,954
62,236
35,997
Diluted average shares
87,768
90,185
71,954
62,236
35,997